Vetsys Pharmaceutical
Vetsys Pharmaceutical
Kuwait's agricultural landscape, particularly its livestock sector, is undergoing a profound transformation. With the harsh desert climate and the strategic push toward food security (Kuwait Vision 2035), the demand for high-efficiency veterinary medicines like Sustained-release Boluses has never been higher. Large-scale farms in regions like Wafra and Abdali are increasingly moving away from traditional daily dosing to advanced, long-acting therapeutic solutions.
Sustained-release boluses represent the pinnacle of veterinary technology. In the intense heat of the Kuwaiti summer, reducing the frequency of animal handling is crucial to preventing heat stress. By providing a steady release of essential nutrients or antibiotics over several weeks or even months, these boluses ensure that camels, sheep, and goats remain healthy without the constant labor costs and stress associated with frequent injections or oral treatments.
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a leading manufacturer in the animal pharmaceutical industry. With a registered capital of 30 million RMB, we have built a reputation for excellence that spans from China to the Middle East. Our facility includes specialized workshops for producing a wide range of products, including powders & premixes, injections, oral solutions, tablets, and sustained-release granules.
Vetsys operates in compliance with strict Good Manufacturing Practices (GMP) to ensure that all products meet the highest quality standards. Over the years, we have grown to become one of the top animal pharmaceutical producers, achieving annual sales of over USD 20 million. Our commitment to Kuwait and the wider GCC region is reflected in our robust supply chain and partnership-driven approach.
Vetsys distinguishes itself by placing a strong emphasis on technological development. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands in Kuwait, producing cutting-edge solutions like long-acting amoxicillin boluses and high-bioavailability premixes.
Quality is the cornerstone of our operations. We adhere to rigorous GMP standards, ensuring that all products undergo extensive quality control checks. Excellence in product quality is essential to the long-term growth and sustainability of the Kuwaiti animal health industry.
Advanced Production Lines for Sustained-Release Veterinary Drugs
As part of our long-term vision, Vetsys is committed to sustainability and global expansion. We invest in green technologies and environmentally friendly practices to minimize our impact. Our products are designed for efficacy and to promote the overall well-being of both animals and the desert environment of Kuwait.
In Kuwait, we are looking to establish deeper partnerships with local veterinary clinics and agricultural cooperatives. Our future strategy includes local research collaborations to specifically target diseases prevalent in the Middle East, such as Hemorrhagic Septicemia and various enteric infections in small ruminants. By combining Chinese manufacturing prowess with Kuwaiti market insights, we aim to lead the industry in the region.
"At Vetsys, we are driven by our mission to improve animal health through continuous innovation, world-class quality, and sustainable practices. We remain committed to creating value for our customers in Kuwait and across the globe."
High-Quality Animal Pharmaceuticals for Export to Kuwait
Join the leading farms in Kuwait using Vetsys sustained-release solutions for better yield and healthier animals.
Send Inquiry Now
